Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A
Condition(s):Genetic DiseaseLast Updated:March 18, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Genetic DiseaseLast Updated:March 18, 2024Active, not recruiting
Condition(s):Dietary Fat MetabolismLast Updated:March 15, 2024Not yet recruiting
Condition(s):HealthyLast Updated:March 15, 2024Not yet recruiting
Condition(s):Tuberous SclerosisLast Updated:March 15, 2024Recruiting
Condition(s):Ulcerative Colitis; Ulcerative Colitis Chronic ModerateLast Updated:March 15, 2024Recruiting
Condition(s):Chronic Low Back PainLast Updated:March 15, 2024Recruiting
Condition(s):HealthyLast Updated:March 12, 2024Recruiting
Condition(s):Genetic DiseaseLast Updated:March 12, 2024Recruiting
Condition(s):Tooth DecayLast Updated:March 8, 2024Completed
Condition(s):Gingivitis; Plaque, DentalLast Updated:March 8, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.